The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bevacizumab, Aflibercept or Ramucirmab combined with chemotherapy as second-line treatment for metastatic colorectal cancer following progression with Bevacizumab in first-line therapy: A systematic review and indirect comparison.
 
Jianwei Zhang
No Relationships to Disclose
 
Yue Cai
No Relationships to Disclose
 
Huabin Hu
No Relationships to Disclose
 
Jiayu Ling
No Relationships to Disclose
 
Jian Xiao
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose